Xue Y - Search Results

1

Editor's Note: PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation via the Activation of Stat3/Bcl-2 Pathway.

Zhang D, He D, Xue Y, Wang R, Wu K, Xie H, Zeng J, Wang X, Zhau HE, Chung LWK, Chang LS, Li L. Zhang D, et al. Among authors: xue y. Cancer Res. 2019 Dec 1;79(23):6054. doi: 10.1158/0008-5472.CAN-19-3162. Cancer Res. 2019. PMID: 31791961 No abstract available.

2

[Impact of PrLZ overexpression on invasion of prostate cancer LNCaP cells in vitro].

Zhang D, Li L, Zhang LL, Xue Y, Wang XY, He DL. Zhang D, et al. Among authors: xue y. Ai Zheng. 2009 May;28(5):483-6. Ai Zheng. 2009. PMID: 19624875 Free article. Chinese.

3

[Identification of TGF-beta/Smads pathway in human prostate cancer cell lines and its significance].

Wu KJ, Zhu GF, Zhang D, Zeng J, Wang XY, Xue Y, Zhang LL, He DL. Wu KJ, et al. Among authors: xue y. Zhonghua Nan Ke Xue. 2009 Oct;15(10):920-4. Zhonghua Nan Ke Xue. 2009. PMID: 20112742 Chinese.

4

[Comparison of transcription factors repressing epithelial phenotype in two different prostate cancer EMT models and its significance].

Wu KJ, Zeng J, Zhu GD, Zhang D, Xue Y, Chen YL, Wang XY, He DL. Wu KJ, et al. Among authors: xue y. Zhonghua Nan Ke Xue. 2010 Feb;16(2):137-41. Zhonghua Nan Ke Xue. 2010. PMID: 20369697 Chinese.

5

Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.

Wu K, Zeng J, Li L, Fan J, Zhang D, Xue Y, Zhu G, Yang L, Wang X, He D. Wu K, et al. Among authors: xue y. Oncol Rep. 2010 Jun;23(6):1545-52. Oncol Rep. 2010. PMID: 20428808

6

Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.

Xue Y, Li L, Zhang D, Wu K, Guo P, Zeng J, Wang X, He D. Xue Y, et al. Oncol Rep. 2010 Dec;24(6):1551-9. doi: 10.3892/or_00001017. Oncol Rep. 2010. PMID: 21042751

7

Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria.

Zeng J, Sun Y, Wu K, Li L, Zhang G, Yang Z, Wang Z, Zhang D, Xue Y, Chen Y, Zhu G, Wang X, He D. Zeng J, et al. Among authors: xue y. Mol Cancer Ther. 2011 Jan;10(1):104-16. doi: 10.1158/1535-7163.MCT-10-0577. Mol Cancer Ther. 2011. PMID: 21220495

8

PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.

Zhang D, He D, Xue Y, Wang R, Wu K, Xie H, Zeng J, Wang X, Zhau HE, Chung LW, Chang LS, Li L. Zhang D, et al. Among authors: xue y. Cancer Res. 2011 Mar 15;71(6):2193-202. doi: 10.1158/0008-5472.CAN-10-1791. Epub 2011 Mar 8. Cancer Res. 2011. PMID: 21385902 Free PMC article.

9

[Epithelial-mesenchymal transition and human fetal prostate development].

Zhou JC, Zhu GD, Wu KJ, Zeng J, Zhang D, Xue Y, Chen YL, Wang XY, He DL. Zhou JC, et al. Among authors: xue y. Zhonghua Nan Ke Xue. 2011 Feb;17(2):146-50. Zhonghua Nan Ke Xue. 2011. PMID: 21404713 Chinese.

10

Detection of survivin expression in cervical cancer cells using molecular beacon imaging: new strategy for the diagnosis of cervical cancer.

Xue Y, An R, Zhang D, Zhao J, Wang X, Yang L, He D. Xue Y, et al. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):204-8. doi: 10.1016/j.ejogrb.2011.06.038. Epub 2011 Jul 12. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21752529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,258 results

Search Page

Filters